In this model, VCaP tumor-bearing mice were castrated when the tumors were approximately 200 mm3 in size, and once the tumor grew back, animals were randomized and treated with enzalutamide and/or the anti-PD-1 antibody pembro, or with vehicle controls. Here, PDCD1 is linked to neoplasm.